首页 | 本学科首页   官方微博 | 高级检索  
检索        

胶质瘤干细胞放射抗拒和放射增敏蛋白质组学研究进展
引用本文:张姗姗,沈云天,范秋虹,田野,黄强.胶质瘤干细胞放射抗拒和放射增敏蛋白质组学研究进展[J].中华放射肿瘤学杂志,2010,29(2):150-153.
作者姓名:张姗姗  沈云天  范秋虹  田野  黄强
作者单位:苏州大学附属第二医院放疗科 215004;
苏州大学附属第二医院神经外科 215004
基金项目:江苏省青年医学人才(QNRC2016859);江苏省医学创新团队A类(CXTDA2017037);苏州市临床医学中心建设项目(Szzxj201503)
摘    要:经过包括放疗在内的多学科治疗,多形性胶质母细胞瘤中位生存期始终停留在1年左右。胶质瘤干细胞基因组和蛋白质组的异质性是影响预后的根本原因,依据蛋白质组学制定针对关键放射抗拒蛋白的增敏研究有望改善多形性胶质母细胞瘤预后。本文通过Pubmed等数据库查阅了近十年来的相关文献,系统地讨论了各种常用蛋白质定量技术、用于数据处理的工具及其在胶质瘤干细胞放射抗拒和放射增敏中的进展。

关 键 词:胶质瘤干细胞  放射敏感性  蛋白质组学  
收稿时间:2019-05-07

Research progress on radiation-resistant and radiation-sensitive proteomics in glioma stem cells
Zhang Shanshan,Shen Yuntian,Fan Qiuhong,Tian Ye,Huang Qiang.Research progress on radiation-resistant and radiation-sensitive proteomics in glioma stem cells[J].Chinese Journal of Radiation Oncology,2010,29(2):150-153.
Authors:Zhang Shanshan  Shen Yuntian  Fan Qiuhong  Tian Ye  Huang Qiang
Institution:Department of Radiotherapy,Second Affiliated Hospital of Soochow University,Suzhou 215004,China;
Department of Neurosurgery,Second Affiliated Hospital of Soochow University,Suzhou 215004,China
Abstract:After multidisciplinary treatment including radiotherapy, the median survival of patients with glioblastoma multiforme (GBM) remains approximately 1 year. The heterogeneity of the genome and proteome of glioblastoma stem cells (GSC) is the fundamental factor affecting the prognosis. Proteomics-based sensitization of key radioresistance proteins is expected to improve the prognosis of GBM patients. In this article, literature review was conducted from PubMed and other databases in the previous 10 years to systematically discuss the research progress on various commonly used protein quantitative techniques, tools for data processing analysis and the application in radioresistance and radiosensitization of GSCs.
Keywords:Gioma stem cell  Radiation sensitivity  Proteomics  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号